✦ LIBER ✦

Predictive Parameters for a Diagnostic Bone Marrow Biopsy Specimen in the Work-Up of Fever of Unknown Origin

✍ Scribed by Ben-Baruch, Sharon; Canaani, Jonathan; Braunstein, Rony; Perry, Chava; Ben-Ezra, Jonathan; Polliack, Aaron; Naparstek, Elizabeth; Herishanu, Yair

Book ID: 122428763
Publisher: Mayo Clinic
Year: 2012
Tongue: English
Weight: 312 KB
Volume: 87
Category: Article
ISSN: 0025-6196
DOI: 10.1016/j.mayocp.2011.08.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Fever of unknown origin: a new definitio

Fever of unknown origin: a new definition and proposal for diagnostic work-up

✍ Elisabeth M.H.A de Kleijn; Daniël C Knockaert; Jos W.M van der Meer 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Diagnostic utility of bone marrow examin

Diagnostic utility of bone marrow examination for the assessment of patients with fever of unknown origin: a 10-year single-centre experience

✍ Labrador, J.; Pérez-López, E.; Martín, A.; Cabrero, M.; Puig, N.; Díez-Campelo, 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB

The diagnostic utility of bone marrow bi

The diagnostic utility of bone marrow biopsies performed for the investigation of fever and/or cytopenias in HIV-infected adults at Groote Schuur Hospital, Western Cape, South Africa

✍ W. A. VAN SCHALKWYK; J. OPIE; N. NOVITZKY 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 261 KB

Comparative yield of blood culture for f

Comparative yield of blood culture for fungi and mycobacteria, liver biopsy, and bone marrow biopsy in the diagnosis of fever of undetermined origin in human immunodeficiency virus-infected patients: Prego V, Glatt AE, Roy V, et al: Arch Intern Med 150:333–336,1990

✍ Charles W. Stratton 📂 Article 📅 1990 🏛 Elsevier Science ⚖ 89 KB

Can multiparametric magnetic resonance i

Can multiparametric magnetic resonance imaging predict upgrading of transrectal ultrasound biopsy results at more definitive histology?11Mohamed Abd-Alazeez receives funding from the Egyptian government. Mark Emberton and Hashim U. Ahmed receive funding from USHIFU and Advanced Medical Diagnostics for clinical trials. Mark Emberton is a paid consultant for Steba Biotech, USHIFU and Sanofi-Aventis. Mark Emberton has received research support by GSK for a study evaluating the role of MRI in men with prostate cancer. Mark Emberton and Hashim Ahmed have previously received medical consultancy fees from GE Healthcare/Oncura and Hashim Ahmed previously from Steba Biotech. Mark Emberton is a medical director of Mediwatch PLC. Hashim Uddin Ahmed and Mark Emberton receive funding from the Medical Research Council, the NIHR-HTA, NIHR-i4i, the US NIH/NCI, Pelican Cancer Foundation, Prostate Cancer UK, and St Peter׳s Trust. This work was part funded by research support for Mark Emberton and Alex Kirkham from the UK National Institute of Health Research UCLH/UCL Comprehensive Biomedical Research Centre, London, UK.

✍ Abd-Alazeez, Mohamed; Ahmed, Hashim U.; Arya, Manit; Allen, Clare; Dikaios, Niko 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 415 KB